PPA
PASG icon

Parametric Portfolio Associates’s Passage Bio PASG Stock Holding History

Parametric Portfolio Associates’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$89K Buy
1,438
+383
+36% +$31.6K ﹤0.01% 3580
2021
Q4 		$134K Buy
+1,055
New +$172K ﹤0.01% 3508
2021
Q3 		– Sell
-1,884
Closed -$499K – 3643
2021
Q2 		$499K Buy
1,884
+617
+49% +$191K ﹤0.01% 3086
2021
Q1 		$443K Buy
1,267
+341
+37% +$146K ﹤0.01% 3558
2020
Q4 		$474K Sell
926
-136
-13% -$54.5K ﹤0.01% 3410
2020
Q3 		$278K Buy
+1,062
New +$365K ﹤0.01% 3519

Other funds holding PASG

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HCM
Highline Capital Management New York $53.5M AUM 21.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Parametric Portfolio Associates's PASG Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Passage Bio (PASG) stake by 36% in Q1 2022, buying an estimated $31.6K and bringing the position to 1,438 shares worth $89K. The position accounts for ﹤0.01% of the portfolio, ranked #3580.

Parametric Portfolio Associates first reported a position in PASG in Q3 2020 and has held it in 6 quarters since. The position peaked at $499K in Q2 2021. 108 funds tracked by Wall St. Rank hold PASG as of Q1 2022.

  • Parametric Portfolio Associates held 1,438 shares of Passage Bio worth $89K as of Q1 2022.
  • Parametric Portfolio Associates bought 383 Passage Bio shares in Q1 2022, an estimated $31.6K.
  • Passage Bio made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3580 holding.
  • Parametric Portfolio Associates first reported a position in Passage Bio in Q3 2020 and has held it in 6 quarters since.
  • Parametric Portfolio Associates's Passage Bio position peaked at $499K in Q2 2021.
  • 108 funds tracked by Wall St. Rank held Passage Bio as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.